Modalis Therapeutics
4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 7.61% |
| Life Science Innovation Management Inc. | 6.28% |
| LSIM Inc. | 5.02% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| SBI SECURITIES Co., Ltd. | 3.77% |
| Osamu Nureki | 3.58% |
| SBI Investment Co., Ltd. | 0.69% |
| Haruhiko Morita | 0.38% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 177
| Holder | Ratio | Change |
|---|---|---|
| Evo Fund2024-07-31 · amended | 11.51% | -1.40pp |
| Evolution Capital Management LLC2024-07-19 · amended | 0.00% | no change |
| Evo Fund2024-07-19 · amended | 12.91% | -5.13pp |
| Evolution Capital Management LLC2024-07-04 · amended | 0.00% | no change |
| Evo Fund2024-07-04 · amended | 18.04% | -1.22pp |
| Haruhiko Morita2024-06-27 · amended | 1.15% | new |
| Life Science Innovation Management Inc.2024-06-27 · amended | 8.97% | new |
| Evolution Capital Management LLC2024-06-24 · amended | 0.00% | no change |
| Evo Fund2024-06-24 · amended | 19.26% | -1.00pp |
| SBI SECURITIES Co., Ltd.2024-06-21 · amended | 1.26% | +0.20pp |
| SBI Investment Co., Ltd.2024-06-21 · amended | 2.77% | -0.34pp |
| SBI SECURITIES Co., Ltd.2024-06-17 · amended | 1.06% | no change |
| SBI Investment Co., Ltd.2024-06-17 · amended | 3.11% | no change |
| Evolution Capital Management LLC2024-06-11 · amended | 0.00% | no change |
| Evo Fund2024-06-11 · amended | 20.26% | -1.17pp |
| Evolution Capital Management LLC2024-06-03 · amended | 0.00% | no change |
| Evo Fund2024-06-03 · amended | 21.43% | -0.47pp |
| Evolution Capital Management LLC2024-05-16 · amended | 0.00% | no change |
| Evo Fund2024-05-16 · amended | 21.90% | -0.98pp |
| SBI SECURITIES Co., Ltd.2024-04-26 · amended | 1.06% | -1.51pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.